We are live on ! Find out more
ESLAW icon

Estrella Immunopharma Warrant
ESLAW

13 hedge funds and large institutions have $239K invested in Estrella Immunopharma Warrant in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

18% more funds holding

Funds holding: 11 → 13 (+2)

13% more capital invested

Capital invested by funds: $212K → $239K (+$26.8K)

1.84% more ownership

Funds ownership: 0% → 1.84% (+1.8%)

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
3
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
+$14.8K
2
Walleye Capital
Walleye Capital
New York
+$5.15K
3
WA
Whitebox Advisors
Minnesota
+$3.54K
4
Walleye Trading
Walleye Trading
New York
+$2.9K
5
WAM
Wolverine Asset Management
Illinois
+$444

Top Sellers

Rank Fund Capital Flow
1
EFI
EHP Funds Inc
Canada
-$41.4K
2
ASM
ATW SPAC Management
New York
-$14.3K
3
MFG
Magnus Financial Group
New York
-$3.77K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$211K +$14.8K +189,899 New
HCM
2
Highbridge Capital Management
New York
$12.4K – – –
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$4.26K – – –
SIA
4
SkyView Investment Advisors
New Jersey
$2K – – –
Walleye Capital
5
Walleye Capital
New York
$1.98K +$5.15K +66,112 New
YCM
6
Yakira Capital Management
Connecticut
$1.4K – – –
WA
7
Whitebox Advisors
Minnesota
$1.36K +$3.54K +45,476 New
Walleye Trading
8
Walleye Trading
New York
$1.12K +$2.9K +37,188 New
CS
9
Clear Street
New York
$858 – – –
CAC
10
Cowen and Company
New York
$857 – – –
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$675 +$267 +3,422 +18%
LCM
12
Landscape Capital Management
New Jersey
$410 – – –
RCM
13
Robinson Capital Management
Michigan
$354 – – –
WAM
14
Wolverine Asset Management
Illinois
$171 +$444 +5,703 New
ASM
15
ATW SPAC Management
New York
– -$14.3K -183,099 Closed
EFI
16
EHP Funds Inc
Canada
– -$41.4K -172,315 Closed
MFG
17
Magnus Financial Group
New York
– -$3.77K -15,695 Closed

ESLAW Hedge Fund Activity: Q4 2023 in Review

13 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q4 2023, worth a combined $239K — up 13% from $212K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ESLAW positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $14.8K. The largest seller was EHP Funds Inc, exiting entirely with an estimated $41.4K sold.

  • 13 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q4 2023, up from 11 in Q3 2023.
  • Funds reported $239K of Estrella Immunopharma Warrant stock for Q4 2023, up 13% quarter-over-quarter.
  • 5 funds opened new Estrella Immunopharma Warrant positions in Q4 2023 and 3 closed out, a net change of +2 holders.
  • The largest Estrella Immunopharma Warrant buyer in Q4 2023 was Boothbay Fund Management, an estimated $14.8K added.
  • The largest Estrella Immunopharma Warrant seller in Q4 2023 was EHP Funds Inc, an estimated $41.4K sold.

Based on aggregated 13F filings for Q4 2023.